SCHEMBL17495271

SCHEMBL17495271

O=C1c2ccccc2C(=O)N1CC1N(C(=O)O)CCC1(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
KEAP1 Q14145 8/20 0.40
NFE2L2 Q16236 3/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17495270 1.00 CA12 (0.42) CA12CA9KEAP1NFE2L2ATM
SCHEMBL19224063 0.84 CTRB1 (0.43) SMN1; SMN2KMT2AMEN1NPSR1CYP2C19
SCHEMBL20956739 0.74 CA12 (0.42) CA12CA9KEAP1NFE2L2ATM
SCHEMBL20956740 0.74 CA12 (0.42) CA12CA9KEAP1NFE2L2ATM
SCHEMBL20956786 0.71 HRH3 (0.48) CA12CA9KEAP1NFE2L2ATM
SCHEMBL5430075 0.71 HRH3 (0.48) CA12CA9KEAP1NFE2L2ATM
SCHEMBL15541653 0.70 CYP1A2 (0.47) CA12CA9ALDH1A1CYP1A2CYP2C9
SCHEMBL21193627 0.70 ALDH1A1 (0.40) CA12CA9KEAP1ALDH1A1CYP1A2
SCHEMBL29239217 0.70 ALDH1A1 (0.40) CA12CA9KEAP1ALDH1A1CYP1A2
SCHEMBL29239214 0.70 ALDH1A1 (0.40) CA12CA9KEAP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3180332-A1 DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS Eolas Therapeutics Inc. (US) 2017-06-21 EP disclosed
WO-2016025669-A1 DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS EOLAS THERAPEUTICS, INC. (US) 2016-02-18 WO disclosed